Clinical Trial Update: EB-OC for the Treatment of Focal Chondral/Osteochondral Defects in the Knee [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update describing a Phase 1/Phase 2 study of EB-OC for focal chondral/osteochondral defects in the knee, with status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chondral Defect
• Osteochondral Defect

Drugs mentioned

• EB-OC

Snippet

Sponsor: Epibone, Inc. | Conditions: Chondral Defect, Osteochondral Defect | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING